ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,432Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 331

$655K Total Retail Price of All Prescriptions

Rank: 12 out of 331

435 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 435 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 11,873 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,091 1,010 1 1
LOSARTAN-HYDROCHLOROTHIAZIDE 865 774 2 14
OMEPRAZOLE 641 590 3 5
LEVOTHYROXINE SODIUM 602 524 4 9
PANTOPRAZOLE SODIUM 429 364 5 41
GABAPENTIN 416 336 6 7
METFORMIN HCL 306 238 7 2
TRAMADOL HCL-ACETAMINOPHEN 267 236 8 18
AMLODIPINE BESYLATE 250 210 9 6
SERTRALINE HCL 225 206 10 28
FAMOTIDINE 218 187 11 50
SINGULAIR 212 205 12 58
ALENDRONATE SODIUM 211 199 13 17
DONEPEZIL HCL 207 207 14 38
DICLOFENAC POTASSIUM 200 167 15 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 199 158 16 79
METOPROLOL SUCCINATE 193 182 17 24
LISINOPRIL 190 182 18 13
EVISTA 188 162 19 61
LOSARTAN POTASSIUM 177 169 20 8
CALCITRIOL 172 162 21 229
RANITIDINE HCL 162 141 22 4
SYNTHROID 153 144 23 11
AMLODIPINE BESYLATE-BENAZEPRIL 140 115 24 47
ATENOLOL 139 130 25 12
TAMSULOSIN HCL 137 124 26 34
CRESTOR 134 99 27 62
GLYBURIDE-METFORMIN HCL 132 119 R 28 54
ACTOS 127 91 29 142
GLIPIZIDE ER 125 98 30 121
DIOVAN HCT 120 107 31 103
ZOLPIDEM TARTRATE 118 107 32 22
CARVEDILOL 110 89 33 33
ATENOLOL-CHLORTHALIDONE 104 99 34 182
GLIPIZIDE XL 99 73 35 88
LEVOXYL 91 91 36 49
VENLAFAXINE HCL ER 89 89 37 219
ACTOPLUS MET 85 72 38 274
PLAVIX 83 82 39 46
FINASTERIDE 82 78 40 74
CLOPIDOGREL 78 76 41 39
MONTELUKAST SODIUM 77 67 42 180
NAMENDA 77 73 42 63
METOPROLOL TARTRATE 76 65 44 16
LANSOPRAZOLE 73 55 45 86
CLEMASTINE FUMARATE 73 65 R 45 236
HYDROCHLOROTHIAZIDE 72 59 47 10
CILOSTAZOL 72 72 47 76
MOMETASONE FUROATE 69 60 49 195
ASPIRIN EC 68 55 50 27
CYMBALTA 66 58 51 113
ESCITALOPRAM OXALATE 61 59 52 218
AMITRIPTYLINE HCL 61 53 R 52 89
GLIMEPIRIDE 58 58 54 21
TRICOR 58 32 54 158
FOSINOPRIL SODIUM 57 57 56 118
TIZANIDINE HCL 57 49 56 117
PIOGLITAZONE HCL 52 47 R 58 332
AZITHROMYCIN 50 43 59 29
FLUOXETINE HCL 50 41 59 102
MECLIZINE HCL 50 48 59 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.